Portal Biliopathy: Comprehensive Structured Summary
Lecture by Prof. Yogesh Chawla, MD, DM
1. Main Clinical Topic(s) Discussed
Portal biliopathy (also termed portal cavernoma cholangiopathy) refers to abnormalities of the biliary system — predominantly extrahepatic, with or without intrahepatic involvement — resulting from extrahepatic portal vein obstruction (EHPVO) leading to portal cavernoma formation and subsequent common bile duct (CBD) compression and ischemic injury.
2. Key Learning Points, Guidelines, and Recommendations
Definition & Pathophysiology
- First described in 1944; modern clinical relevance highlighted after a landmark 1989–1992 case report demonstrating biliary obstruction reversal following surgical portal decompression
- Two critical pathophysiological mechanisms:
- Compression by dilated pericholedochal venous plexus (plexus of Petren) → reversible indentation/scalloping of bile duct
- Ischemic stricturing from thrombosis of small arterioles/venules supplying the bile duct → irreversible fibrotic strictures
- Secondary infection → subclinical cholangitis → inflammation, neoangiogenesis, and fibrosis compound biliary injury
- The pericholedochal plexus of Petren (parallel collateral vessels) is the primary driver of biliary abnormalities; the epicholedochal plexus of Saint is less implicated
- The infraduodenal bile duct is least vascularized and most prone to ischemic injury
Nomenclature
- Multiple historical terms: pseudosclerosing cholangitis, portal ductopathy, portal hypertensive biliopathy
- Indian National Association for Study of Liver (INASL) recommended: *"Portal Cavernoma Cholangiopathy"*
- Also occurs (less extensively described) in cirrhosis and non-cirrhotic portal fibrosis (NCPF)
Classification Systems
- By Location (Sarin's group):
- Type 1: Extrahepatic involvement only
- Type 2: Intrahepatic involvement only
- Type 3A: Extrahepatic + unilateral intrahepatic
- Type 3B: Extrahepatic + bilateral intrahepatic
- Grade 1: Irregularities and angulations
- Grade 2: Strictures without dilation
- Grade 3: Strictures with upstream dilation
- By Type (Japanese classification): Varicoid, fibrotic, or mixed
Diagnostic Approach
- Screening: Ultrasound with Doppler — identifies portal cavernoma, serpiginous collaterals, biliary dilation, gallbladder varices, choledocholithiasis
- Gold standard: MRCP with portography — delineates both biliary and vascular anatomy non-invasively; differentiates stones from varices; provides roadmap for intervention
- CT scan: No longer preferred due to repeated radiation exposure
- ERCP: Reserved for therapeutic intervention only (not diagnostic)
- Endoscopic ultrasound (EUS): Superior to MRCP for distinguishing CBD stones from varices; useful pre-endotherapy planning
- Diagnosis requires: Portal cavernoma on imaging + characteristic cholangiographic alterations + exclusion of PSC, cholangiocarcinoma, biliary ascariasis, IgG4 cholangiopathy, HIV cholangiopathy
3. Specific Clinical Data, Statistics, and Study Results Cited
| Finding | Data |
|---|
| Symptomatic portal biliopathy prevalence | 5–38% of EHPVO patients |
| Biliary abnormalities on ERCP (asymptomatic EHPVO) | ~100% of patients |
| Left hepatic duct involvement vs. right | More frequent involvement of left hepatic duct |
| Intrahepatic + extrahepatic abnormalities on MRI (pediatric, <13 yrs) | 85% of 53 asymptomatic patients; severe abnormalities in 58% |
| Symptomatic patients: time |